CommercialPrior AuthMedium impact
08.02.42a, Penpulimab-kcqx
Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
Jun 1, 2026
We identified it
Jun 19, 2026
Summary
A new medical necessity criteria policy for Penpulimab-kcqx (a pharmacy benefit drug) has been updated for commercial insurance plans. This affects prior authorization requirements and coverage determinations for this specific medication.
Action Required
Before June 1, 2026: Billing team and providers must review updated medical necessity criteria for Penpulimab-kcqx prescriptions. Update prior authorization workflows to ensure compliance with new criteria. Verify coverage requirements in billing system for commercial plans to prevent claim denials.